Human Data First: New Biological Premises for Arteriovenous Fistula Research.

Area of Science:

• Vascular Surgery
• Nephrology
• Biomedical Engineering

Background:

• Arteriovenous fistula (AVF) maturation for hemodialysis remains a significant clinical challenge, with approximately 40% of AVFs failing to become usable.
• Existing biological models focusing on intimal hyperplasia are insufficient to explain early AVF failure, despite decades of research and failed clinical trials.

Purpose of the Study:

• To redefine the biological framework of early AVF failure by shifting from a reductionist, animal-model-centric view to a human-centered perspective.
• To integrate human observational data with experimental findings to provide a comprehensive understanding of AVF maturation and failure.

Main Methods:

• Review of existing literature, emphasizing human observational research and clinical trial data.
• Incorporation of experimental data to elucidate mechanistic insights into AVF biology.
• Development of a two-phase model of AVF maturation: acute biomechanical response and subsequent vascular healing/remodeling.

Main Results:

• The prevailing model of AVF failure, centered on intimal hyperplasia, is inadequate.
• A new model integrating acute biomechanical responses and vascular healing processes offers a more comprehensive understanding of AVF maturation.
• This framework highlights differences between human and animal biology in AVF development.

Conclusions:

• A human-centered biological framework is crucial for advancing AVF research and clinical practice.
• Understanding the distinct phases of AVF maturation, from initial biomechanics to long-term remodeling, is key to addressing failure rates.
• Meaningful innovation in AVF biology is achievable through a cohesive, human-focused approach, leading to improved therapeutic opportunities.